Related references
Note: Only part of the references are listed.Structures of plasmepsin X from Plasmodium falciparum reveal a novel inactivation mechanism of the zymogen and molecular basis for binding of inhibitors in mature enzyme
Pooja Kesari et al.
PROTEIN SCIENCE (2022)
Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax
Anthony N. Hodder et al.
STRUCTURE (2022)
Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials
Maelle Duffey et al.
TRENDS IN PARASITOLOGY (2021)
Transport mechanisms at the malaria parasite-host cell interface
Josh R. Beck et al.
PLOS PATHOGENS (2021)
Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness
Barbara H. Stokes et al.
ELIFE (2021)
A target safety assessment of the potential toxicological risks of targeting plasmepsin IX/X for the treatment of malaria
Jane Barber et al.
TOXICOLOGY RESEARCH (2021)
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle
Paola Favuzza et al.
CELL HOST & MICROBE (2020)
Plasmepsin Inhibitors in Antimalarial Drug Discovery: Medicinal Chemistry and Target Validation (2000 to Present)
Peter Mubanga Cheuka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Malaria parasite plasmepsins: More than just plain old degradative pepsins
Armiyaw S. Nasamu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Cellular thermal shift assay for the identification of drug-target interactions in the Plasmodium falciparum proteome
Jerzy Michal Dziekan et al.
NATURE PROTOCOLS (2020)
The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management
Tulasi Yadati et al.
CELLS (2020)
Molecular Mechanisms of Drug Resistance in Plasmodium falciparum Malaria
Kathryn J. Wicht et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 74, 2020 (2020)
Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity
Manu Vanaerschot et al.
CELL CHEMICAL BIOLOGY (2020)
Structural Insights Into Key Plasmodium Proteases as Therapeutic Drug Targets
Manasi Mishra et al.
FRONTIERS IN MICROBIOLOGY (2019)
The Development Process for Discovery and Clinical Advancement of Modern Antimalarials
Trent D. Ashton et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
A dual target of Plasmepsin IX and X: Unveiling the atomistic superiority of a core chemical scaffold in malaria therapy
Geraldene Munsamy et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay
Jerzy M. Dziekan et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases
Budhaditya Mukherjee et al.
EMBO JOURNAL (2018)
Egress and invasion machinery of malaria: an in-depth look into the structural and functional features of the flap dynamics of plasmepsin IX and X
Geraldene Munsamy et al.
RSC ADVANCES (2018)
Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
Judite R. M. Coimbra et al.
FRONTIERS IN CHEMISTRY (2018)
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
Leila S. Ross et al.
NATURE COMMUNICATIONS (2018)
Comparison of methods for the prediction of human clearance from hepatocyte intrinsic clearance for a set of reference compounds and an external evaluation set
Tetsuo Yamagata et al.
XENOBIOTICA (2017)
New developments in anti-malarial target candidate and product profiles
Jeremy N. Burrows et al.
MALARIA JOURNAL (2017)
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic
Benjamin Blasco et al.
NATURE MEDICINE (2017)
Plasmepsins IX and X are essential and draggable mediators of malaria parasite egress and invasion
Armiyaw S. Nasamu et al.
SCIENCE (2017)
A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress
Paco Pino et al.
SCIENCE (2017)
Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase
Tanya Paquet et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A druggable secretory protein maturase of Toxoplasma essential for invasion and egress
Sunil Kumar Dogga et al.
ELIFE (2017)
Synthesis of amino heterocycle aspartyl protease inhibitors
Rachel K. Chambers et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients
Matthew E. Kennedy et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors
Andrea M. Zuhl et al.
NATURE COMMUNICATIONS (2016)
Subtle Changes in Endochin-Like Quinolone Structure Alter the Site of Inhibition within the Cytochrome bc1 Complex of Plasmodium falciparum
Allison M. Stickles et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Long-term live imaging reveals cytosolic immune responses of host hepatocytes against Plasmodium infection and parasite escape mechanisms
Monica Prado et al.
AUTOPHAGY (2015)
Rate- and Extent-Limiting Factors of Oral Drug Absorption: Theory and Applications
Kiyohiko Sugano et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
A novel multiple-stage antimalarial agent that inhibits protein synthesis
Beatriz Baragana et al.
NATURE (2015)
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
Margaret A. Phillips et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Retinal Toxicity Induced by a Novel -secretase Inhibitor in the Sprague-Dawley Rat
Mark R. Fielden et al.
TOXICOLOGIC PATHOLOGY (2015)
BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer's disease
Arun K. Ghosh et al.
CHEMICAL SOCIETY REVIEWS (2014)
Evaluation of Aminohydantoins as a Novel Class of Antimalarial Agents
Marvin J. Meyers et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Flexibility of the flap in the active site of BACE1 as revealed by crystal structures and molecular dynamics simulations
Yechun Xu et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2012)
ß-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment
Jun Cai et al.
EMBO MOLECULAR MEDICINE (2012)
The cellular and molecular basis for malaria parasite invasion of the human red blood cell
Alan F. Cowman et al.
JOURNAL OF CELL BIOLOGY (2012)
A framework for assessing the risk of resistance for anti-malarials in development
Xavier C. Ding et al.
MALARIA JOURNAL (2012)
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
Joanne Bowes et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
P. falciparum In Vitro Killing Rates Allow to Discriminate between Different Antimalarial Mode-of-Action
Laura M. Sanz et al.
PLOS ONE (2012)
Iminoheterocycle as a druggable motif: BACE1 inhibitors and beyond
Zhaoning Zhu
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Proteases in Malaria Parasites - A Phylogenomic Perspective
Hong Cai et al.
CURRENT GENOMICS (2011)
Species Differences in Distribution and Prediction of Human Vss from Preclinical Data
Loren M. Berry et al.
DRUG METABOLISM AND DISPOSITION (2011)
The Corrected Traditional Equations for Calculation of Hepatic Clearance that Account for the Difference in Drug Ionization in Extracellular and Intracellular Tissue Water and the Corresponding Corrected PBPK Equation
Leonid M. Berezhkovskiy
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
Stephan Meister et al.
SCIENCE (2011)
An Invitation to Open Innovation in Malaria Drug Discovery: 47 Quality Starting Points from the TCAMS
Felix Calderon et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I-Inhibitor Design and Validation
Zhaoning Zhu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Thousands of chemical starting points for antimalarial lead identification
Francisco-Javier Gamo et al.
NATURE (2010)
Improved Murine Model of Malaria Using Plasmodium falciparum Competent Strains and Non-Myelodepleted NOD-scid IL2Rγnull Mice Engrafted with Human Erythrocytes
Maria Belen Jimenez-Diaz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Quantitative Measurement of Plasmodium-Infected Erythrocytes in Murine Models of Malaria by Flow Cytometry Using Bidimensional Assessment of SYTO-16 Fluorescence
Maria Belen Jimenez-Diaz et al.
CYTOMETRY PART A (2009)
A multifunctional serine protease primes the malaria parasite for red blood cell invasion
Konstantinos Koussis et al.
EMBO JOURNAL (2009)
A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human Erythrocytes
Inigo Angulo-Barturen et al.
PLOS ONE (2008)
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Ian W. Davis et al.
NUCLEIC ACIDS RESEARCH (2007)
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models
Christopher Snyder et al.
EXPERIMENTAL PARASITOLOGY (2007)
PHENIX:: building new software for automated crystallographic structure determination
PD Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2002)
Share Paper
